Literature DB >> 12949894

Ineffective erythropoiesis in the spleen of a patient with pyruvate kinase deficiency.

Shin Aizawa1, Urara Kohdera, Masaki Hiramoto, Yutaka Kawakami, Ken-ichi Aisaki, Yohnosuke Kobayashi, Shiro Miwa, Hisaichi Fujii, Hitoshi Kanno.   

Abstract

In this study, possible adverse effects of pyruvate kinase (PK) deficiency on the maturation of erythroid progenitors were investigated. A 4-year-old Japanese girl with severe PK deficiency underwent splenectomy to reduce her need for blood transfusions. The spleen was examined a histologically, and the hematopoietic progenitors in the spleen were assayed to evaluate the extramedullary hematopoiesis of this PK-deficient subject. The number of hematopoietic progenitors including CFU-GM, BFU-E and CFU-GEMM in the spleen of the PK-deficient patient was much higher than those found in control spleens, indicating enhanced extramedullary hematopoiesis. TUNEL assay demonstrated apoptotic cells in the splenic red pulp of the PK-deficient patient. The expression of 7A6 antigen was detected in cells isolated from spleen and in cells cultured in vitro, but only in those cells that were positive for glycophorin A. These results provide evidence that the metabolic disturbances in PK deficiency affect not only the survival of red cells but also the maturation of erythroid progenitors, which results in premature cell death, i.e., apoptosis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949894     DOI: 10.1002/ajh.10380

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  Growth differentiation factor 15 in erythroid health and disease.

Authors:  Toshihiko Tanno; Pierre Noel; Jeffery L Miller
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

2.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

3.  Iron Loading and Overloading due to Ineffective Erythropoiesis.

Authors:  Toshihiko Tanno; Jeffery L Miller
Journal:  Adv Hematol       Date:  2010-05-11

4.  AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency.

Authors:  Charles Kung; Jeff Hixon; Penelope A Kosinski; Giovanni Cianchetta; Gavin Histen; Yue Chen; Collin Hill; Stefan Gross; Yaguang Si; Kendall Johnson; Byron DeLaBarre; Zhiyong Luo; Zhiwei Gu; Gui Yao; Huachun Tang; Cheng Fang; Yingxia Xu; Xiaobing Lv; Scott Biller; Shin-San Michael Su; Hua Yang; Janeta Popovici-Muller; Francesco Salituro; Lee Silverman; Lenny Dang
Journal:  Blood       Date:  2017-07-31       Impact factor: 22.113

5.  Carbamazepine-induced hemolytic and aplastic crises associated with reduced glutathione peroxidase activity of erythrocytes.

Authors:  Masaki Yamamoto; Nobuhiro Suzuki; Naoki Hatakeyama; Noriaki Kubo; Nobutada Tachi; Hitoshi Kanno; Hisaichi Fujii; Hiroyuki Tsutsumi
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.